| CL3322 |
|
330829-30-6 |
N-((3-苯甲酰氨基苯基)氨基甲硫酰基)-3,4,5-三甲氧基苯甲酰胺
MRT-10 (MRT 10)
-
98+%
|
需詢價 |
C24H23N3O5S |
|
|
|
| CL3321 |
|
306387-90-6 |
3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine
KAAD-Cyclopamine (Synonyms: Cyclopamine-KAAD;3-Keto-N-aminoethyl-N’-aminocaproyldihydrocinnamoyl Cyclopamine)
-
98+%
|
需詢價 |
C44H63N3O4 |
|
|
|
| HL2024 |
|
1429-30-7 |
氯化矮牽牛素; 牽?；ㄉ? 矮牽牛氯化物
Petunidin Chloride
-
98+%
|
需詢價 |
C16H13ClO7 |
|
|
|
| CL3312 |
|
1535212-07-7 |
(33R,34S,35S,91R,92R,5S)-5-(叔丁基)-N-((1R,2R)-2-(二氟甲基)-1-(((1-甲基環(huán)丙基)磺酰基)氨基甲?；?環(huán)丙基)-34-乙基-14,14-二氟-17-甲氧基-4,7-二氧代-2,8-二氧雜-6-氮雜-1(2,3)-喹喔啉-3(3,1)-吡咯烷-9(1,2)-環(huán)丙烷環(huán)十四烷-35-甲酰胺; 伏西瑞韋
Voxilaprevir (Synonyms:GS-9857)
-
99+%
|
需詢價 |
C40H52F4N6O9S |
|
|
|
| CL3310 |
|
2728667-27-2 |
N-(1-(8-((3-甲基-4-((1-甲基-1H-苯并[d]咪唑-5-基)氧基)苯基)氨基)嘧啶并[5,4-d]嘧啶-2-基)哌啶-4-基)丙烯酰胺
Zongertinib (Synonyms: BI 1810631;BI 764532)
-
98+%
|
需詢價 |
C29H29N9O2 |
|
|
|
| CLR1543 |
|
2413428-37-0 |
(S)-5-芐基-18-(2,5-二氧代-2,5-二氫-1-吡咯基)-4,7,10,13-四氧代-3,6,9,12-四氮雜十八烷-1-酸(2,5-二氧代吡咯烷-1-基)酯
MC-GGFG-OSu (MC-Gly-Gly-Phe-Gly-OSu); 2,5-Dioxopyrrolidin-1-yl (S)-5-Benzyl-18-(2,5-dioxo-2,5-dihydro-1-pyrrolyl)-4,7,10,13-tetraoxo-3,6,9,12-tetraazaoctadecan-1-oate
-
98+%
|
需詢價 |
C29H34N6O10 |
|
|
|
| CL3301B |
|
732302-99-7 |
吉諾司他鹽酸鹽一水合物
Givinostat hydrochloride monohydrate (Synonyms: ITF-2357 hydrochloride monohydrate)
-
98+%
|
需詢價 |
C24H30ClN3O5 |
|
|
|
| CL3301A |
|
199657-29-9 |
Givinostat hydrochloride (ITF-2357 hydrochloride)
Givinostat hydrochloride (Synonyms: ITF-2357 hydrochloride)
-
98+%
|
需詢價 |
C24H28ClN3O4 |
|
|
|
| CL3301 |
|
497833-27-9 |
Givinostat (ITF-2357)
Givinostat (Synonyms: ITF-2357)
-
98+%
|
需詢價 |
C24H27N3O4 |
|
|
|
| CL3300 |
|
60660-75-5 |
伊達比星酮; (7S,9S)9-乙?；?7,8,9,10-四氫-6,7,9,11-四羥基-5,12-并四苯二酮
Idarubicinone(Idarubicin Aglycone); (7S,9S)-9-Acetyl-6,7,9,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione
-
98+%
|
需詢價 |
C20H16O7 |
|
|
|
| CL1457A |
|
1256589-74-8 |
9-乙基-6,6-二甲基-8-(4-嗎啉-4-基哌啶-1-基)-11-氧代-5H-苯并[b]咔唑-3-腈鹽酸鹽;艾樂替尼鹽酸鹽;鹽酸阿來替尼
Alectinib Hydrochloride (Synonyms: CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride;Alectinib HCl)
-
99+%
|
需詢價 |
C30H35ClN4O2 |
|
|
|
| CL3293 |
|
2869954-35-6 |
N-(2-氯-4-(三氟甲基)苯基)-2-(2-(3,6-二氫-2H-吡喃-4-基)-5-乙基-6-(4-(5-羥基-6-甲基嘧啶-4-羰基)哌嗪-1-基)-7-氧代-[1,2,4]三唑并[1,5-a]嘧啶-4(7H)-基)乙酰胺鈉鹽
Werner syndrome RecQ helicase-IN-1 sodium (EX-A7900;G65952); N-(2-Chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl)-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide, sodium salt
-
98+%
|
需詢價 |
C31H31ClF3N9NaO5 |
|
|
|
| HL2004 |
|
52117-69-8 |
短葉松素-3-乙酸酯
Pinobanksin 3-acetate ((2R,3R)-Pinobanksin 3-acetate; Pinobanksin 3-O-acetate; Pinobanksin acetate)
-
98+%
|
需詢價 |
C17H14O6 |
|
|
|
| HL1380A |
|
142825-10-3 |
L-蘿卜硫素; 萊菔硫烷;(R)-1-異硫氰酸基-4-（甲亞磺酰基）-丁烷; 4-甲基亞磺?；』惲蚯杷狨?/p>
(R)-Sulforaphane (Synonyms: L-Sulforaphane; (R)-1-Isothiocyanato-4-(methylsulfinyl)butane; 4-Methylsulfinylbutyl isothiocyanate)
-
95+%
|
需詢價 |
C6H11NOS2 |
|
|
|
| CL3246 |
|
102121-60-8 |
AM580
AM580 (Synonyms: CD336; NSC608001; Ro 40-6055)
-
98+%
|
需詢價 |
C22H25NO3 |
|
|
|
| CL3234 |
|
1188379-43-2 |
Insulin Icodec
Insulin Icodec
-
98+%
|
需詢價 |
C280H435N71O87S6 |
|
|
|
| CL3227A |
|
2119669-71-3 |
Asciminib hydrochloride
Asciminib hydrochloride (Synonyms: ABL001 hydrochloride)
-
98+%
|
需詢價 |
C20H19Cl2F2N5O3 |
|
|
|
| CL3227 |
|
1492952-76-7 |
Asciminib
Asciminib (Synonyms: ABL001)
-
98+%
|
需詢價 |
C20H18ClF2N5O3 |
|
|
|
| CL3193 |
|
1366302-52-4 |
(3S,7S)-22-(3-(((2-((5-(2-羧乙基)-2-羥基芐基)(羧甲基)氨基)乙基)(羧甲基)氨基)甲基)-4-羥基苯基)-5,13,20-三氧代-4,6,12,19-四氮雜二十二烷-1,3,7-三羧酸
PSMA-11 (Synonyms: HBED-CC-PSMA; Psma-hbed-CC; PSMA11;PSMA-11 free base;Gozetotide)
-
98+%
|
需詢價 |
C44H62N6O17 |
|
|
|
| CL3192 |
|
1341200-45-0 |
度博替尼; 杜貝馬丁尼（TP-0903）
Dubermatinib (Synonyms: TP-0903)
-
98+%
|
需詢價 |
C24H30ClN7O2S |
|
|
|
